BCS Bioceramic Sealer
BCS Device Pte., Ltd. · Decision date Oct 16, 2026
What did the FDA decide?
The FDA's 510(k) record K262478 covers the BCS Bioceramic Sealer, submitted by BCS Device Pte., Ltd. of Singapore. The device falls under product code KIF, classified as a resin for root canal filling, with Dental as the regulation medical specialty and review panel. The application was a traditional 510(k) received on 07/20/2026 and was not reviewed by a third party.
On 10/16/2026, FDA recorded a decision of Substantially Equivalent (SESE) for K262478. That decision is a 510(k) clearance, not a premarket approval. The record does not include a predicate device, a summary of the technological comparison, or the indications for use, so the specific component or changed item assessed and the basis for the equivalence finding remain unknown from this page. No combination product or authorized predetermined change control plan is recorded.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Oct 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262478
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- BCS Device Pte., Ltd.
- Product code
- KIF
- Decision code
- SESE
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Resin, Root Canal Filling.
- Applicant
- BCS Device Pte., Ltd.
- Product code
- KIF
- FDA device class
- 2
FDA decision timeline
K262478 received
Application receipt date recorded by FDA.
K262478 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code KIF
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Vioseal XK262050 | Spident Co., Ltd. | 510(k) clearance | Sep 11, 2026 | FDA |
| NuSmile, Ltd. | 510(k) clearance | Sep 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
BCS Device Pte., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Singapore
Sources and methodology
- Original FDA record: K262478
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
